What is Bioventix PLC (BVXP.L)?

Bioventix PLC (BVXP.L) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Bioventix PLC (BVXP.L)

Stock analysis · LSE · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.54

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Bioventix PLC (BVXP.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Oct 26, 2026

EPS $0.75 vs est. $0.66

Beat by $0.09

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bioventix PLC

Bioventix PLC focuses on the development, manufacturing, and global provision of sheep monoclonal antibodies (SMAs) for various diagnostic purposes. The company's extensive product line features purified SMAs that facilitate testing for critical areas such as thyroid conditions, vitamin D deficiencies, cardiac health markers, detection of drugs of abuse, fertility assessments, infectious diseases, oncology, and other diverse medical indications. Additionally, Bioventix PLC offers tailored contract SMA development and specialized recombinant services. The London, UK-based firm was established in 2003.